These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15060767)

  • 1. [Differential diagnosis of chronic inflammatory diseases of the central nervous system. Cerebrospinal fluid diagnosis and immunological parameters].
    Reske D; Petereit HF
    Nervenarzt; 2004 Oct; 75(10):945-52. PubMed ID: 15060767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Difficulties in the differentiation of chronic inflammatory diseases of the central nervous system--value of cerebrospinal fluid analysis and immunological abnormalities in the diagnosis.
    Reske D; Petereit HF; Heiss WD
    Acta Neurol Scand; 2005 Oct; 112(4):207-13. PubMed ID: 16146488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of an immunopathogenic basis for central nervous system disease in primary Sjögren's syndrome.
    Alexander EL; Lijewski JE; Jerdan MS; Alexander GE
    Arthritis Rheum; 1986 Oct; 29(10):1223-31. PubMed ID: 2429673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Polyspecific immune reaction in the central nervous system in autoimmune diseases with CNS involvement].
    Graef IT; Henze T; Reiber H
    Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):587-91. PubMed ID: 7856266
    [No Abstract]   [Full Text] [Related]  

  • 5. Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis.
    Alexander EL; Malinow K; Lejewski JE; Jerdan MS; Provost TT; Alexander GE
    Ann Intern Med; 1986 Mar; 104(3):323-30. PubMed ID: 3946977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid anti-SSA autoantibodies in primary Sjogren's syndrome with central nervous system involvement.
    Mégevand P; Chizzolini C; Chofflon M; Roux-Lombard P; Lalive PH; Picard F
    Eur Neurol; 2007; 57(3):166-71. PubMed ID: 17213724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of masqueraders of autoimmune disease in the office.
    Frieri M
    Allergy Asthma Proc; 2003; 24(6):421-9. PubMed ID: 14763244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of activated terminal complement (C5b-9) in cerebrospinal fluid from patients with central nervous system involvement of primary Sjogren's syndrome or systemic lupus erythematosus.
    Sanders ME; Alexander EL; Koski CL; Frank MM; Joiner KA
    J Immunol; 1987 Apr; 138(7):2095-9. PubMed ID: 3559203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurosarcoidosis mimicking Sjögren's syndrome.
    Tuisku IS; Konttinen YT; Soinila S; Karma A; Tervo TM
    Acta Ophthalmol Scand; 2004 Oct; 82(5):599-602. PubMed ID: 15453861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central nervous system disease in primary Sjögren's syndrome.
    De Backer H; Dehaene I
    Acta Neurol Belg; 1995; 95(3):142-6. PubMed ID: 7484051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Internal medicine and neurological diseases: progress in diagnosis and treatment topics: X. Neurological disorders in connective tissue disease].
    Tomizawa Y; Yokoyama K; Hattori N
    Nihon Naika Gakkai Zasshi; 2012 Aug; 101(8):2242-8. PubMed ID: 22973697
    [No Abstract]   [Full Text] [Related]  

  • 12. Acute Neurologic Manifestations of Systemic Immune-Mediated Diseases.
    Galetta K; Bhattacharyya S
    Semin Neurol; 2021 Oct; 41(5):541-553. PubMed ID: 34619780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of immunoglobulins synthesis with central nervous system involvement in Neuro-Behçet's disease.
    Zhan H; Cheng L; Liu Y; Xu H; Feng X; Liu Y; Li H; Li Z; Wang S; Jin H; Zheng W; Hao H; Li Y
    Clin Chim Acta; 2024 Jun; 559():119681. PubMed ID: 38643816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibodies against aquaporin-4 in patients with neuropsychiatric systemic lupus erythematosus and primary Sjögren's syndrome.
    Wandinger KP; Stangel M; Witte T; Venables P; Charles P; Jarius S; Wildemann B; Probst C; Iking-Konert C; Schneider M
    Arthritis Rheum; 2010 Apr; 62(4):1198-200. PubMed ID: 20131265
    [No Abstract]   [Full Text] [Related]  

  • 15. Limited utility of current MRI criteria for distinguishing multiple sclerosis from common mimickers: primary and secondary CNS vasculitis, lupus and Sjogren's syndrome.
    Kim SS; Richman DP; Johnson WO; Hald JK; Agius MA
    Mult Scler; 2014 Jan; 20(1):57-63. PubMed ID: 23736535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular manifestations of systemic inflammatory diseases.
    Mohsenin A; Huang JJ
    Conn Med; 2012 Oct; 76(9):533-44. PubMed ID: 23155672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction: of syndromes and interfaces.
    Ehrlich GE
    Rheumatology; 1973; 4(0):1-12. PubMed ID: 4151988
    [No Abstract]   [Full Text] [Related]  

  • 18. Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases.
    Sanders ME; Alexander EL; Koski CL; Shin ML; Sano Y; Frank MM; Joiner KA
    Ann N Y Acad Sci; 1988; 540():387-8. PubMed ID: 3207265
    [No Abstract]   [Full Text] [Related]  

  • 19. Acute pan-dysautonomia: a rare initial presentation of lupus with sjogren's syndrome.
    Law WG; Thong BY; Umapathi T; Chng HH
    Lupus; 2006; 15(12):899-900. PubMed ID: 17211999
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymorphous meningitis with atypical mononuclear cells in Sjögren's syndrome.
    de la Monte SM; Hutchins GM; Gupta PK
    Ann Neurol; 1983 Oct; 14(4):455-61. PubMed ID: 6638957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.